The Global Surgical Sealants and Adhesives Market Size is valued at 2.64 Billion in 2022 and is predicted to reach 6.26 Billion by the year 2031 at a 10.23 % CAGR during the forecast period for 2023-2031.
Surgical adhesives and sealants are substances with natural or synthetic origins that are added to sutures in order to prevent infection, repair damaged tissue boundaries, and speed healing. Given their capacity to reduce blood loss, enhance closure, and enable less painful and easier operations without the need for removal, these materials are emerging as potential substitutes for staples and sutures in many medical applications. The market for surgical sealants and adhesives is anticipated to expand as chronic health conditions like cardiovascular disease, kidney illness, neurological problems, and others are becoming more common. Another reason boosting the market for surgical sealants and adhesives is the rise in car accidents requiring urgent procedures.
Market Segmentation:
The surgical sealants and adhesives market is divided into product, indication, and application. Based on product, the market is segmented into Natural/Biological Sealants and Adhesives and Synthetic and Semi-synthetic Sealants and Adhesives. Based on indication, the surgical sealants and adhesives market is segmented into Surgical Hemostasis, Tissue Sealing, Tissue Engineering. Based on application, the market is bifurcated and divided into General Surgeries, Cardiovascular Surgeries, Central Nervous System Surgeries, Orthopedic Surgeries, Urological Surgeries, and Others.
Based on product, the biological segment is a major contributor to the surgical sealants and adhesives market.
The market's leading segment is the biological segment. Fibrin, collagen, and gelatin-based sealants and adhesives are further categories for natural or biological materials because of the many medical settings in which they are used. They are useful in thoracic, cardiovascular, orthopedic, neuro, and reconstructive operations. Additionally, only fibrin and other sealants have FDA permission for usage in all three categories, namely hemostats, sealants, and adhesives.
The central nervous system (CNS) segment witnessed growth at a rapid rate.
The central nervous system (CNS) category had the highest revenue share since CNS illnesses are quite common worldwide. In CNS procedures, sealants are preferred to conventional closure techniques, including wires, sutures, and staples. Because traditional sealant techniques are challenging to use in CNS surgeries, there is an exponentially growing need for surgical sealants and adhesives for CNS.
North America holds a significant regional revenue share.
The North American region market is expected to register the highest market share. This is majorly due to some elements, including the prevalence of chronic health conditions, an increase in age-related health problems, essential businesses engaged in manufacturing surgical sealants and adhesives, cutting-edge medical facilities, etc. One of the key elements fueling the growth of the North American surgical sealants and adhesives market is the increased frequency of chronic conditions needing surgery, notably in the United States. Besides, the Asia Pacific region is estimated to hold the largest share of the market. The aging population is propelling the surgical sealants and adhesives market, which is more likely to experience health issues, including heart disease, bone disease, eye problems, and others that call for immediate surgery.
Competitive Landscape
Some major key players in the Global Surgical Sealants and Adhesives Market:
- Bard,
- Johnson & Johnson (UK),
- Baxter International,
- Medtronic plc (US),
- Braun Melsungen AG (Germany),
- Cohera Medical,
- Sanofi Group (France),
- Sealantis,
- Vivostat A/S (Denmark),
- Ocular Therapeutics
Global Surgical Sealants and Adhesives Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 2.64 Billion |
|
Revenue Forecast In 2031 |
USD 6.26 Billion |
|
Growth Rate CAGR |
CAGR of 10.23% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Product, Indication, Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
R. Bard, Johnson & Johnson (UK), Baxter International, Medtronic plc (US), Braun Melsungen AG (Germany), Cohera Medical, Sanofi Group (France), Sealantis, Vivostat A/S (Denmark), Ocular Therapuetix |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
